Close Menu
Home » Oxford Nanopore

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments — MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

 

CEO: Gordon Sanghera

Website: www.nanoporetech.com

Ticker symbol: Privately held

Headquarters: Oxford, UK

Number of employees: 250+

Jul 18, 2019

European Patent Office Revokes Second Pacific Biosciences Patent

The patent, EP3170904, "Compositions and methods for nucleic acid sequencing," is the second PacBio patent revoked by the EPO this year. 

Jul 08, 2019

Oxford Nanopore 2018 Revenues More Than Double; Firm Opens New Production Facility

In a message posted on Twitter today, Oxford Nanopore said that revenues grew to $43.7 million last year, up from $17.8 million in 2017.

May 24, 2019

Oxford Nanopore Previews Upcoming Products, Outlines Nanopore-Based DNA Data Storage Tech

Premium

At the company's annual user meeting in London, staff members previewed upgrades and changes that will result in higher throughput and accuracy at lower sequencing costs.

Apr 29, 2019

GrandOmics, Oxford Nanopore Partner on 100K Human Genomes Structural Variation Project

The project plans to sequence 20,000 genomes in 2019, 50,000 by the end of 2020, and a total of 100,000 by the end of 2021 using Oxford Nanopore's PromethIon platform.

Apr 19, 2019

Oxford Nanopore Sequencing Shows Promise for Diagnosing Prosthetic Joint Infections

Premium

The method, presented at the European Congress of Clinical Microbiology and Infectious Diseases, may provide results in hours rather than a week or more.

Apr 16, 2019

Consortium Catalogs Structural Variation in Human Genomes Using Combination of Tools

The study used a variety of sequencing and mapping technologies, including from Illumina, Pacific Biosciences, 10X Genomics, Bionano Genomics, and Oxford Nanopore.

Mar 26, 2019

New Human Genome Reference Projects Combine Long Nanopore Reads, Other Data Types

Premium

The Telomere-to-Telomere consortium has already generated a gapless assembly of the human X chromosome and aims to complete all chromosomes over the next two years or so.

Mar 25, 2019

Clear Labs, Oxford Nanopore Ink North American Distribution Agreement for Food Safety Testing

Clear Labs will implement Oxford Nanopore's GridIon nanopore sequencing instrument with its Clear Safety platform to detect food-borne pathogens.

Mar 25, 2019

Clear Labs Turns to Nanopore Sequencing for Food Safety Testing

Premium

The firm claims that its Clear Safety platform will help food safety professionals detect food-borne pathogens and prevent outbreaks across the US.

Mar 18, 2019

Nanopore Sequencing Adapter Enables Low-Cost Experiments, May Broaden Technology's Use

Premium

Early-access users of the Flongle said the small, inexpensive flow cells allow them to develop new methods quickly and to check the quality of clones and libraries.

Pages

The Scan

Some More Than Others

A new analysis finds some cancers receive more nonprofit dollars than others.

Another Look

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

Gene Variant's Possible Role

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

Science Finds Sex-Biased Gene Expression in Mammals, More

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.

What's Popular?

In Oxford Nanopore

  1. European Patent Office Revokes Second Pacific Biosciences Patent

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.